Literature DB >> 9573282

Analysis of a vaccinia virus mutant expressing a nonpalmitylated form of p37, a mediator of virion envelopment.

D W Grosenbach1, D E Hruby.   

Abstract

Vaccinia virus encodes a 37-kDa palmitylated protein (p37) that is required for envelopment, translocation, and cell-to-cell spread of virions. We have analyzed the biological significance of the palmitate modification by constructing a recombinant vaccinia virus that expresses a nonpalmitylated p37 and comparing its biological activity to that of the wild-type virus. The mutant virus is inefficient at cell-to-cell spread and does not produce or release enveloped virions, although it produces normal amounts of nonenveloped virions. Furthermore, the mutant virus is not able to nucleate actin to propel itself through and out of the cell, a function requiring the indirect participation of p37. The deficiency in protein function appears to result from a lack of appropriate targeting to the membranes of the trans-Golgi network (TGN) which leaves p37 soluble in the cytoplasm. We conclude that the palmitate moiety is necessary for targeting or anchoring p37 to the TGN membrane, where, along with other vaccinia virus-encoded proteins, p37 is involved in the complex process of virion envelopment and release.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9573282      PMCID: PMC110078          DOI: 10.1128/JVI.72.6.5108-5120.1998

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  50 in total

1.  IPTG-dependent vaccinia virus: identification of a virus protein enabling virion envelopment by Golgi membrane and egress.

Authors:  J F Rodriguez; G L Smith
Journal:  Nucleic Acids Res       Date:  1990-09-25       Impact factor: 16.971

2.  The complete DNA sequence of vaccinia virus.

Authors:  S J Goebel; G P Johnson; M E Perkus; S W Davis; J P Winslow; E Paoletti
Journal:  Virology       Date:  1990-11       Impact factor: 3.616

Review 3.  Posttranslational modification of vaccinia virus proteins.

Authors:  J K VanSlyke; D E Hruby
Journal:  Curr Top Microbiol Immunol       Date:  1990       Impact factor: 4.291

4.  Extracellular vaccinia virus formation and cell-to-cell virus transmission are prevented by deletion of the gene encoding the 37,000-Dalton outer envelope protein.

Authors:  R Blasco; B Moss
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

5.  Mutagenesis of phospholipase D defines a superfamily including a trans-Golgi viral protein required for poxvirus pathogenicity.

Authors:  T C Sung; R L Roper; Y Zhang; S A Rudge; R Temel; S M Hammond; A J Morris; B Moss; J Engebrecht; M A Frohman
Journal:  EMBO J       Date:  1997-08-01       Impact factor: 11.598

6.  Localization and fine structure of a vaccinia virus gene encoding an envelope antigen.

Authors:  P Hirt; G Hiller; R Wittek
Journal:  J Virol       Date:  1986-06       Impact factor: 5.103

7.  Use of a cell-free system to identify the vaccinia virus L1R gene product as the major late myristylated virion protein M25.

Authors:  C A Franke; E M Wilson; D E Hruby
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

8.  Neomycin resistance as a dominant selectable marker for selection and isolation of vaccinia virus recombinants.

Authors:  C A Franke; C M Rice; J H Strauss; D E Hruby
Journal:  Mol Cell Biol       Date:  1985-08       Impact factor: 4.272

9.  Characterization of intracellular and extracellular vaccinia virus variants: N1-isonicotinoyl-N2-3-methyl-4-chlorobenzoylhydrazine interferes with cytoplasmic virus dissemination and release.

Authors:  G Hiller; H Eibl; K Weber
Journal:  J Virol       Date:  1981-09       Impact factor: 5.103

10.  Fatty acid acylation of vaccinia virus proteins.

Authors:  C A Franke; P L Reynolds; D E Hruby
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

View more
  11 in total

1.  Intracellular trafficking of a palmitoylated membrane-associated protein component of enveloped vaccinia virus.

Authors:  Matloob Husain; Bernard Moss
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

Review 2.  Phospholipase D: enzymology, functionality, and chemical modulation.

Authors:  Paige E Selvy; Robert R Lavieri; Craig W Lindsley; H Alex Brown
Journal:  Chem Rev       Date:  2011-09-22       Impact factor: 60.622

3.  Vaccinia virus F13L protein with a conserved phospholipase catalytic motif induces colocalization of the B5R envelope glycoprotein in post-Golgi vesicles.

Authors:  M Husain; B Moss
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

4.  Intracellular localization of vaccinia virus extracellular enveloped virus envelope proteins individually expressed using a Semliki Forest virus replicon.

Authors:  M M Lorenzo; I Galindo; G Griffiths; R Blasco
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

5.  Inhibition of vaccinia virus L1 N-myristoylation by the host N-myristoyltransferase inhibitor IMP-1088 generates non-infectious virions defective in cell entry.

Authors:  Lalita Priyamvada; Wouter W Kallemeijn; Monica Faronato; Kimberly Wilkins; Cynthia S Goldsmith; Catherine A Cotter; Suany Ojeda; Roberto Solari; Bernard Moss; Edward W Tate; Panayampalli Subbian Satheshkumar
Journal:  PLoS Pathog       Date:  2022-10-10       Impact factor: 7.464

6.  Similarities in the induction of post-Golgi vesicles by the vaccinia virus F13L protein and phospholipase D.

Authors:  Matloob Husain; Bernard Moss
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

7.  An orally bioavailable antipoxvirus compound (ST-246) inhibits extracellular virus formation and protects mice from lethal orthopoxvirus Challenge.

Authors:  Guang Yang; Daniel C Pevear; Marc H Davies; Marc S Collett; Tom Bailey; Susan Rippen; Linda Barone; Chris Burns; Gerry Rhodes; Sanjeev Tohan; John W Huggins; Robert O Baker; R L Mark Buller; Erin Touchette; Kem Waller; Jill Schriewer; Johan Neyts; Erik DeClercq; Kevin Jones; Dennis Hruby; Robert Jordan
Journal:  J Virol       Date:  2005-10       Impact factor: 6.549

Review 8.  Chewing the Fat: The Conserved Ability of DNA Viruses to Hijack Cellular Lipid Metabolism.

Authors:  Philip T Lange; Michael Lagunoff; Vera L Tarakanova
Journal:  Viruses       Date:  2019-01-29       Impact factor: 5.048

9.  A36-dependent actin filament nucleation promotes release of vaccinia virus.

Authors:  Jacquelyn Horsington; Helena Lynn; Lynne Turnbull; Delfine Cheng; Filip Braet; Russell J Diefenbach; Cynthia B Whitchurch; Guna Karupiah; Timothy P Newsome
Journal:  PLoS Pathog       Date:  2013-03-21       Impact factor: 6.823

10.  Vaccinia virus p37 interacts with host proteins associated with LE-derived transport vesicle biogenesis.

Authors:  Yali Chen; Kady M Honeychurch; Guang Yang; Chelsea M Byrd; Chris Harver; Dennis E Hruby; Robert Jordan
Journal:  Virol J       Date:  2009-04-28       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.